Palvella Therapeutics, Inc 10-K for FY2024
Palvella Therapeutics, Inc. (PVLA)
10-K
2025-03-31
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
Palvella Therapeutics, Inc filed this 10-K on March 31, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $17.43M
- compared with net income of $18.69M a year earlier
- Diluted EPS
- -$7.83
- compared with $2.17 a year earlier